The European Patent Office (EPO) Publishes Grounds for its Decision to Refuse Two Patent Applications Naming a Machine as Inventor
The EPO has published on 27 January 2020 its decision setting out the reasons for its recent refusal of two European patent applications in which an Artificial Intelligence (AI) system was designated as the inventor.
Filed by an individual in autumn 2018, the applications EP 18 275 163 and EP 18 275 174 were refused by the EPO following oral proceedings with the applicant in November 2019, on the grounds that they do not meet the legal requirement of the European Patent Convention (EPC) that an inventor designated in the application has to be a human being, and not a machine.
In both applications, the machine called “DABUS”, which is described as “a type of connectionist artificial intelligence”, is named as the inventor. The applicant stated that he had acquired the right to the European patent from the inventor by being its successor in title, arguing that as the machine’s owner, he was assigned any intellectual property rights created by this machine.
In its decisions, the EPO considered that the interpretation of the legal framework of the European patent system leads to the conclusion that the inventor designated in a …Read More
By Marta García
On January 8, 2019, the Brazilian National Institute of Industrial Property (INPI) and CAS, a division of the American Chemical Society that specializes in scientific information solutions, announced that they have initiated a collaboration to speed up the patent examination process at INPI through the use of artificial intelligence (AI) tools.
CAS´s AI solution combines scoring similarity, workflow classification and knowledge-space exploration capabilities to provide patent examiners with a comprehensive set of prior art in the relevant field of technology, as well as information already published that may be relevant to the examination, helping to expedite the examination process.
“CAS´s technology can help INPI examiners quickly uncover relevant scientific information, a promising development for shortening the time of patent application processing,” said Luiz Otávio Pimentel, former President of INPI.
As recently reported in our blog, according to the INPI´s 2018 Activity Report, the average decision time for patent applications in Brazil is currently 10 years, with pharma and IT patent applications reaching a maximum average of 13 years.
Therefore, this collaboration with CAS is among the several measures that the INPI has been implementing since 2016 with the aim of tackling one of the biggest patent …Read More